Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Congress 2021

16 - 21 Sep 2021

Paris, Virtual, France

ESMO Congress 2021 - 1000x1000

All resources are available according to the presenters' agreement to release them.

Abstracts and ePosters are open access.

Slides and webcasts are reserved to ESMO Members.

ESMO thanks the authors for their generosity.
The use of these presentations is for personal educational purposes only.

"ESMO Congress 2021:  The place where oncology experts come together, as a community." - Solange Peters, ESMO President

ESMO Members: Login to access all Congress resources!

Just out: ESMO21 Spotlights to make sure you keep up to date with practice changing results.

Just enter an abstract number, or author name in the search to find it. Remember to put multiple words between quotes ("triple negative").

Expert reports videos  |  Highlight videos  |  Congress News

Guidelines session (open access)

ESMO Colloquium

Hide
Filter by:

There are 2789 resources available

Discussion 1038MO and 1039MO

Presenter: Teresa Petrella

Session: Mini oral session - Melanoma and other skin tumours

Resources:

Slides

Webcast

Discussion LBA67 and 1743MO

Presenter: Laura Locati

Session: Mini oral session - NETs and endocrine tumours

Resources:

Slides

Webcast

Discussion 515MO and 516MO

Presenter: Aung Naing

Session: Mini oral session - Developmental therapeutics

Resources:

Slides

Webcast

Discussion 517MO and 518MO

Presenter: Richard Schlenk

Session: Mini oral session - Developmental therapeutics

Resources:

Slides

Webcast

Discussion 519MO and 520MO

Presenter: Richard Baird

Session: Mini oral session - Developmental therapeutics

Resources:

Slides

Webcast

Introduction by the chair

Presenter: Edward Garon

Session: Patients with metastatic progression on or shortly after durvalumab consolidation for stage III NSCLC should be treated

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.